<VariationArchive RecordType="classified" VariationID="1723336" VariationName="NC_000009.11:g.(?_108456805)_(108468035_108483817)del" VariationType="Deletion" Accession="VCV001723336" Version="1" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2022-11-19" DateCreated="2022-11-19" MostRecentSubmission="2022-11-19">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="1780827" VariationID="1723336">
      <GeneList>
        <Gene Symbol="TMEM38B" FullName="transmembrane protein 38B" GeneID="55151" HGNC_ID="HGNC:25535" Source="submitted" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>9q31.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="9" Accession="NC_000009.12" start="105694541" stop="105776629" display_start="105694541" display_stop="105776629" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="9" Accession="NC_000009.11" start="108456824" stop="108537443" display_start="108456824" display_stop="108537443" Strand="+" />
          </Location>
          <OMIM>611236</OMIM>
        </Gene>
      </GeneList>
      <Name>NC_000009.11:g.(?_108456805)_(108468035_108483817)del</Name>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>9q31.2</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" forDisplay="true" AssemblyStatus="previous" Chr="9" Accession="NC_000009.11" innerStart="108456805" innerStop="108468035" outerStop="108483817" display_start="108456805" display_stop="108483817" variantLength="27013" />
      </Location>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000009.11" sequenceAccession="NC_000009" sequenceVersion="11" change="g.(?_108456805)_(108468035_108483817)del" Assembly="GRCh37">
            <Expression>NC_000009.11:g.(?_108456805)_(108468035_108483817)del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NC_000009.11:g.(?_108456805)_(108468035_108483817)del AND Osteogenesis imperfecta" Accession="RCV002308612" Version="1">
        <ClassifiedConditionList TraitSetID="5689">
          <ClassifiedCondition DB="MedGen" ID="C0029434">Osteogenesis imperfecta</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-10-18" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2022-10-18" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2022-11-19" MostRecentSubmission="2022-11-19">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">24835313</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">27441836</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">32123938</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="5689" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="6312" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Osteogenesis imperfecta</ElementValue>
                <XRef ID="Osteogenesis+imperfecta/5451" DB="Genetic Alliance" />
                <XRef ID="MONDO:0019019" DB="MONDO" />
                <XRef Type="Phenotypic series" ID="PS166200" DB="OMIM" />
                <XRef ID="78314001" DB="SNOMED CT" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">OI</ElementValue>
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">COL1A1/2 osteogenesis imperfecta (COL1A1/2-OI) is characterized by fractures with minimal or absent trauma, variable dentinogenesis imperfecta (DI), and, in adult years, hearing loss. The clinical features of COL1A1/2-OI represent a continuum ranging from perinatal lethality to individuals with severe skeletal deformities, mobility impairments, and very short stature to nearly asymptomatic individuals with a mild predisposition to fractures, normal dentition, normal stature, and normal life span. Fractures can occur in any bone but are most common in the extremities. DI is characterized by gray or brown teeth that may appear translucent, wear down, and break easily. COL1A1/2-OI has been classified into four types based on clinical presentation and radiographic findings. This classification system can be helpful in providing information about prognosis and management for a given individual. The four more common OI types are now referred to as follows: Classic non-deforming OI with blue sclerae (previously OI type I). Perinatally lethal OI (previously OI type II). Progressively deforming OI (previously OI type III). Common variable OI with normal sclerae (previously OI type IV).</Attribute>
                <XRef ID="NBK1295" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="1017" />
                <XRef ID="1017" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301472</ID>
                <ID Source="BookShelf">NBK1295</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG, 2006">
                <ID Source="pmc">3110960</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG, 2008">
                <ID Source="pmc">3111019</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="EMQN, 2012">
                <ID Source="pmc">3234509</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="Orphanet, 2008">
                <URL>https://www.orpha.net/data/patho/Pro/en/Emergency_OsteogenesisImperfecta.pdf</URL>
                <CitationText>Orphanet Emergency Guidelines: Osteogenesis imperfecta (OI)</CitationText>
              </Citation>
              <XRef ID="666" DB="Orphanet" />
              <XRef ID="C0029434" DB="MedGen" />
              <XRef ID="D010013" DB="MeSH" />
              <XRef ID="MONDO:0019019" DB="MONDO" />
              <XRef Type="Phenotypic series" ID="PS166200" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="5082108" SubmissionDate="2022-11-10" DateLastUpdated="2022-11-19" DateCreated="2022-11-19">
        <ClinVarSubmissionID localKey="NC_000009.11:g.(?_108456805)_(108468035_108483817)del|MedGen:C0029434" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002600561" DateUpdated="2022-11-19" DateCreated="2022-11-19" Type="SCV" Version="1" SubmitterName="Women's Health and Genetics/Laboratory Corporation of America, LabCorp" OrgID="500026" OrganizationCategory="laboratory" OrgAbbreviation="WHG-LC" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-10-18">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">27441836</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">32123938</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">24835313</ID>
          </Citation>
          <Comment>Variant summary: The variant identified by MLPA or other technology involves the deletion of exons 1-2 in the TMEM38B gene. A presumed nomenclature of c.(?_-137)_(269+1_270-1)del has been designated for the purposes of this classification. Although exact breakpoints of this copy number variant are not known, it is expected to result in a large deletion in the TMEM38B gene, including the initiation codon and is predicted to result either in absence of the protein or truncation of the encoded protein due to translation initiation at a downstream codon. An alternative downstream in-frame start codon (Met117) is located in the encoded protein. An activation of potential downstream translation initiation site would result in a shortened protein missing the first 116 amino acids from the protein sequence. The variant allele was found at a frequency of 4.6e-05 in 21694 control chromosomes (gnomAD, Structural Variants database). Deletion of exons 1-2 has been reported in the literature in multiple homozygous and compound heterozygous individuals affected with Osteogenesis Imperfecta (e.g. Rubinato_2014, Cabral_2016, Fernandes_2020). These data indicate that the variant is very likely to be associated with disease. At least one publication reports experimental evidence evaluating an impact on protein function. In this study, a total absence of TRIC-B protein was demonstrated in fibroblast and osteoblast lysates from a patient who was compound heterozygous for this variant and another loss-of-function variant, suggesting that both variants were non-functional (Cabral_2016). Three submitters have provided clinical-significance assessments for this variant to ClinVar after 2014. Two classified the variant as pathogenic and one classified it as VUS. Based on the evidence outlined above, the variant was classified as pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">LabCorp Variant Classification Summary - May 2015</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/rtxspsnt/labcorp_variant_classification_method_-_may_2015.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="TMEM38B" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000009.11:g.(?_108456805)_(108468035_108483817)del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0029434" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12274151</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="5082108" TraitType="Disease" MappingType="XRef" MappingValue="C0029434" MappingRef="MedGen">
        <MedGen CUI="C0029434" Name="Osteogenesis imperfecta" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

